{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:56:56Z","timestamp":1772067416136,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Pain"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ynpai.2021.100067","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T09:28:45Z","timestamp":1626341325000},"page":"100067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7388-4834","authenticated-orcid":false,"given":"K.N.","family":"Westlund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Montera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Goins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8532-8950","authenticated-orcid":false,"given":"S.R.A.","family":"Alles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Afaghpour-Becklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-3522","authenticated-orcid":false,"given":"R.","family":"Bartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Durvasula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kunamneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ynpai.2021.100067_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004714-199512000-00007","article-title":"A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder","volume":"15","author":"Adams","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.ynpai.2021.100067_b0010","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1021\/jm050921q","article-title":"Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors","volume":"49","author":"Agnes","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ynpai.2021.100067_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin Dev Immunol."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"Etiology and Pharmacology of Neuropathic Pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.ynpai.2021.100067_b0025","first-page":"3081","article-title":"A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial","volume":"6","author":"Alvarez","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ynpai.2021.100067_b0030","doi-asserted-by":"crossref","unstructured":"Andre J, Zeau B, Pohl M, Cesselin F, Benoliel JJ, Becker C. Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies. J Neurosci. 2005;31;25(35):789\u201376904. doi:10.1523\/JNEUROSCI.0743-05.2005.","DOI":"10.1523\/JNEUROSCI.0743-05.2005"},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03687-x","article-title":"Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis","volume":"9","author":"Angelini","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0040","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1471-4159.1999.720858.x","article-title":"Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cord","volume":"72","author":"Antunes Bras","year":"1999","journal-title":"J. Neurochem."},{"issue":"46","key":"10.1016\/j.ynpai.2021.100067_b0045","doi-asserted-by":"crossref","first-page":"10410","DOI":"10.1523\/JNEUROSCI.2541-04.2004","article-title":"Chronic back pain is associated with decreased prefrontal and thalamic gray matter density","volume":"24","author":"Apkarian","year":"2004","journal-title":"J Neurosci Off J Soc Neurosci."},{"issue":"5","key":"10.1016\/j.ynpai.2021.100067_b0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/19420862.2017.1325052","article-title":"Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges","volume":"9","author":"Ayoub","year":"2017","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.ynpai.2021.100067_b0055","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0333102417706310","article-title":"Neuropathic orofacial pain: Facts and fiction","volume":"37","author":"Baad-Hansen","year":"2017","journal-title":"Cephalalgia Int J Headache."},{"issue":"8","key":"10.1016\/j.ynpai.2021.100067_b0060","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nn.3153","article-title":"Corticostriatal functional connectivity predicts transition to chronic back pain","volume":"15","author":"Baliki","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ynpai.2021.100067_b0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12688\/wellcomeopenres.14641.1","article-title":"Distinct transcriptional responses of mouse sensory neurons in models of human chronic pain conditions","volume":"3","author":"Bangash","year":"2018","journal-title":"Wellcome Open Res."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and Molecular Mechanisms of Pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ynpai.2021.100067_b0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coph.2016.09.002","article-title":"Potential clinical indications for a CCK2 receptor antagonist","volume":"31","author":"Boyce","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.ynpai.2021.100067_b0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.ynpai.2021.100067_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: past and future clinical research strategies","volume":"61","author":"Bradwejn","year":"2001","journal-title":"Scand J. Clin. Lab. Investig. Suppl."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pneurobio.2011.11.004","article-title":"Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins","volume":"97","author":"Butler","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ynpai.2021.100067_b0095","doi-asserted-by":"crossref","unstructured":"Danaher RJ, Zhang L, Donley CJ, et al. Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model. Mol Pain. 2018;14:1744806918796763. doi:10.1177\/1744806918796763.","DOI":"10.1177\/1744806918796763"},{"issue":"6","key":"10.1016\/j.ynpai.2021.100067_b0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0149-7634(98)00011-6","article-title":"CCK in Anxiety and Cognitive Processes","volume":"22","author":"Daug\u00e9","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.ynpai.2021.100067_b0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","article-title":"Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings","volume":"46","author":"de Montigny","year":"1989","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.ynpai.2021.100067_b0110","doi-asserted-by":"crossref","unstructured":"Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;Aug;87(2):149-58. PMID:10924808.","DOI":"10.1016\/S0304-3959(00)00276-1"},{"issue":"23","key":"10.1016\/j.ynpai.2021.100067_b0115","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the Treatment of Migraine","volume":"381","author":"Dodick","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ynpai.2021.100067_b0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-4939-8648-4_13","article-title":"Rapid selection of high-affinity antibody scFv fragments using ribosome display","volume":"1827","author":"Dreier","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ynpai.2021.100067_b0125","doi-asserted-by":"crossref","unstructured":"Friedrich AE, Gebhart GF. Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla. Pain. 2003;Jul;104(1-2):93-101. doi:10.1016\/s0304-3959(02)00469-4.","DOI":"10.1016\/S0304-3959(02)00469-4"},{"issue":"12","key":"10.1016\/j.ynpai.2021.100067_b0130","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1523\/JNEUROSCI.12-12-04854.1992","article-title":"Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions","volume":"12","author":"Ghilardi","year":"1992","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.ynpai.2021.100067_b0135","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2235","article-title":"Nociceptor sensitization in pain pathogenesis","volume":"16","author":"Gold","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ynpai.2021.100067_b0140","doi-asserted-by":"crossref","unstructured":"Gutierrez-Mecinas M, Bell AM, Shepherd F, et al. Expression of cholecystokinin by neurons in mouse spinal dorsal horn. J Comp Neurol. Published online August 1, 2019.","DOI":"10.1002\/cne.24657"},{"issue":"4","key":"10.1016\/j.ynpai.2021.100067_b0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5607\/en.2017.26.4.179","article-title":"Spike Frequency Adaptation in Neurons of the Central Nervous System","volume":"26","author":"Ha","year":"2017","journal-title":"Exp Neurobiol."},{"key":"10.1016\/j.ynpai.2021.100067_b0150","doi-asserted-by":"crossref","unstructured":"Hashmi JA, Baliki MN, Huang L, et al. Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain J Neurol. 2013;136(Pt 9):2751-2768. doi:10.1093\/brain\/awt211.","DOI":"10.1093\/brain\/awt211"},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.11607\/jop.1154","article-title":"Painful traumatic trigeminal neuropathy: an open study on the pharmacotherapeutic response to stepped treatment","volume":"28","author":"Haviv","year":"2014","journal-title":"J Oral Facial Pain Headache."},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1152\/jn.2001.85.1.280","article-title":"Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla","volume":"85","author":"Heinricher","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ynpai.2021.100067_b0165","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2147\/JPR.S187715","article-title":"Anxiety-induced hyperalgesia in female rats is mediated by cholecystokinin 2 receptor in rostral ventromedial medulla and spinal 5-hydroxytryptamine 2B receptor","volume":"12","author":"Jiang","year":"2019","journal-title":"J. Pain Res."},{"issue":"10","key":"10.1016\/j.ynpai.2021.100067_b0170","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0024-3205(98)00012-5","article-title":"The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats","volume":"62","author":"Kayser","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ynpai.2021.100067_b0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/JPR.S232714","article-title":"Rediscovery of ceruletide, a CCK agonist, as an analgesic drug","volume":"13","author":"Keppel Hesselink","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ynpai.2021.100067_b0180","doi-asserted-by":"crossref","unstructured":"Kim YP, Park D, Kim JJ, et al. Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor. PLoS One. 2014;1;9(12):e113442. doi:10.1371\/journal.pone.0113442.","DOI":"10.1371\/journal.pone.0113442"},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbr.2007.10.020","article-title":"Gene expression profiling reveals upregulation of Tlr4 receptors in Cckb receptor deficient mice","volume":"188","author":"K\u00f5ks","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.ynpai.2021.100067_b0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ejp.1174","article-title":"Differential gene expression in trigeminal ganglia of male and female rats following chronic constriction of the infraorbital nerve","volume":"22","author":"Korczeniewska","year":"2018","journal-title":"Eur. J. Pain Lond. Engl."},{"issue":"3","key":"10.1016\/j.ynpai.2021.100067_b0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-3959(00)00290-6","article-title":"Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat","volume":"87","author":"Kovelowski","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ynpai.2021.100067_b0200","doi-asserted-by":"crossref","unstructured":"Kramer MS, Cutler NR, Ballenger JC, et al. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995;1;37(7):462-466. doi:10 1016 0006-3223 94 00190-.","DOI":"10.1016\/0006-3223(94)00190-E"},{"issue":"50","key":"10.1016\/j.ynpai.2021.100067_b0205","doi-asserted-by":"crossref","first-page":"16835","DOI":"10.1523\/JNEUROSCI.2755-14.2014","article-title":"Antibody-derived in vivo imaging of tau pathology","volume":"34","author":"Krishnaswamy","year":"2014","journal-title":"J Neurosci Dec."},{"issue":"11","key":"10.1016\/j.ynpai.2021.100067_b0210","doi-asserted-by":"crossref","first-page":"e0205743","DOI":"10.1371\/journal.pone.0205743","article-title":"Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies","volume":"13","author":"Kunamneni","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4269\/ajtmh.18-0658","article-title":"Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display","volume":"101","author":"Kunamneni","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.ynpai.2021.100067_b0220","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1460-9568.2004.03619.x","article-title":"Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice","volume":"20","author":"Kurrikoff","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41591-020-1142-7","article-title":"A neuroimaging biomarker for sustained experimental and clinical pain","volume":"27","author":"Lee","year":"2021","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ynpai.2021.100067_b0230","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/j.pain.0000000000001914","article-title":"A transcriptional toolbox for exploring peripheral neuroimmune interactions","volume":"161","author":"Liang","year":"2020","journal-title":"Pain"},{"issue":"77","key":"10.1016\/j.ynpai.2021.100067_b0235","first-page":"28503137","article-title":"Reward network immediate early gene expression in mood disorders","volume":"11","author":"Manning","year":"2017","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-8993(96)00477-5","article-title":"On the distribution of cholecystokinin B receptors in monkey brain","volume":"738","author":"Mercer","year":"1996","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.ynpai.2021.100067_b0245","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.pbb.2006.11.014","article-title":"Cholecystokinin is necessary for the expression of morphine conditioned place preference","volume":"85","author":"Mitchell","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ynpai.2021.100067_b0250","doi-asserted-by":"crossref","unstructured":"Montera MA, Westlund KN. Minimally Invasive Oral Surgery Induction of the FRICT-ION Chronic Neuropathic Pain Model. Bio-Protoc. 2020;10(8):e3591-e3591.","DOI":"10.21769\/BioProtoc.3591"},{"issue":"5","key":"10.1016\/j.ynpai.2021.100067_b0255","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/jn.00611.2013","article-title":"Reorganization of hippocampal functional connectivity with transition to chronic back pain","volume":"111","author":"Mutso","year":"2014","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1087057115610070","article-title":"Isolation of potent CGRP neutralizing antibodies using four simple assays","volume":"21","author":"Neal","year":"2016","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ynpai.2021.100067_b0265","doi-asserted-by":"crossref","unstructured":"North RY, Li Y, Ray P, et al. Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons. Brain. 2019;142(5):1215-1226. doi: 10.1093\/brain\/awz063.","DOI":"10.1093\/brain\/awz063"},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1358\/dot.2020.56.1.3069863","article-title":"Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache","volume":"56","author":"Ossipov","year":"2020","journal-title":"Drugs Today Barc."},{"issue":"12","key":"10.1016\/j.ynpai.2021.100067_b0275","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/14712598.2019.1671350","article-title":"Monoclonal antibodies for the prevention of migraine","volume":"19","author":"Raffaelli","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"issue":"27","key":"10.1016\/j.ynpai.2021.100067_b0280","doi-asserted-by":"crossref","first-page":"19760","DOI":"10.1074\/jbc.M112.426288","article-title":"Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor","volume":"288","author":"Ravn","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ynpai.2021.100067_b0285","doi-asserted-by":"crossref","unstructured":"Rehfeld, J.F., 2000. Cholecystokinin and panic disorder\u2013three unsettled questions. Regul. Pept. 93(1\u20133). 10. 1016 0167-0115 00 00179-8.","DOI":"10.1016\/S0167-0115(00)00179-8"},{"issue":"3","key":"10.1016\/j.ynpai.2021.100067_b0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/protein\/gzn052","article-title":"Engineered antibody intervention strategies for Alzheimer\u2019s disease and related dementias by targeting amyloid and toxic oligomers","volume":"22","author":"Robert","year":"2009","journal-title":"Protein Eng. Sel."},{"issue":"3","key":"10.1016\/j.ynpai.2021.100067_b0295","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1440-1746.1992.tb00983.x","article-title":"Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes","volume":"7","author":"Roberts-Thomson","year":"1992","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14712598.6.2.177","article-title":"Ribosome display for improved biotherapeutic molecules","volume":"6","author":"Rothe","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"issue":"171\u2013181","key":"10.1016\/j.ynpai.2021.100067_b0305","first-page":"12790157","article-title":"Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models","volume":"28","author":"Rotzinger","year":"2003","journal-title":"J. Psychiatry Neurosci."},{"issue":"1-3","key":"10.1016\/j.ynpai.2021.100067_b0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(01)00281-6","article-title":"Identification of CCK-B\/gastrin receptor splice variants in human peripheral blood mononuclear cells","volume":"101","author":"Schmitz","year":"2001","journal-title":"Regul. Pept."},{"issue":"8","key":"10.1016\/j.ynpai.2021.100067_b0315","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1067\/S1526-5900(03)00781-8","article-title":"Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis","volume":"4","author":"Shields","year":"2003","journal-title":"J. Pain. Off. J. Am. Pain Soc."},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12010-012-9962-7","article-title":"Recombinant single-chain antibody with the Trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier","volume":"169","author":"\u0160krlj","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40259-012-0007-0","article-title":"Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B\/gastrin receptor by phage display technology","volume":"27","author":"Tohidkia","year":"2013","journal-title":"BioDrugs."},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0330","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hbm.23696","article-title":"Altered structure and functional connection in patients with classical trigeminal neuralgia","volume":"39","author":"Tsai","year":"2018","journal-title":"Hum. Brain Mapp."},{"issue":"7","key":"10.1016\/j.ynpai.2021.100067_b0335","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/aww100","article-title":"Corticolimbic anatomical characteristics predetermine risk for chronic pain","volume":"139","author":"Vachon-Presseau","year":"2016","journal-title":"Brain J Neurol."},{"issue":"3","key":"10.1016\/j.ynpai.2021.100067_b0340","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.brainresrev.2004.07.004","article-title":"Descending control of persistent pain: inhibitory or facilitatory?","volume":"46","author":"Vanegas","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"6","key":"10.1016\/j.ynpai.2021.100067_b0345","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jpain.2010.12.007","article-title":"Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats","volume":"12","author":"Vera-Portocarrero","year":"2011","journal-title":"J. Pain"},{"issue":"11","key":"10.1016\/j.ynpai.2021.100067_b0350","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1523\/JNEUROSCI.1787-13.2014","article-title":"Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of \u0394FosB","volume":"34","author":"Vialou","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"4647","key":"10.1016\/j.ynpai.2021.100067_b0355","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.6546809","article-title":"Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide","volume":"224","author":"Watkins","year":"1984","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ynpai.2021.100067_b0360","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/S0140525X97261480","article-title":"Central inhibitory dysfunctions: mechanisms and clinical implications","volume":"20","author":"Wiesenfeld-Hallin","year":"1997","journal-title":"Behav Brain Sci."},{"issue":"6","key":"10.1016\/j.ynpai.2021.100067_b0365","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0773.2002.910619.x","article-title":"The role of spinal cholecystokinin in chronic pain states","volume":"91","author":"Wiesenfeld-Hallin","year":"2002","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ynpai.2021.100067_b0370","doi-asserted-by":"crossref","unstructured":"Xie JY, Herman DS, Stiller CO, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci. 2005;12;25(2):409-16. doi:10.1523\/JNEUROSCI.4054-04.2005.","DOI":"10.1523\/JNEUROSCI.4054-04.2005"},{"key":"10.1016\/j.ynpai.2021.100067_b0375","doi-asserted-by":"crossref","unstructured":"Xu XJ, Puke MJ, Verge VM, Wiesenfeld-Hallin Z, Hughes J, H\u00f6kfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci Lett. 1993;2;152(1-2):129-32. doi:10 1016 0304-3940 93 90500-.","DOI":"10.1016\/0304-3940(93)90500-K"},{"issue":"2","key":"10.1016\/j.ynpai.2021.100067_b0380","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0143-4179(96)90088-8","article-title":"L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies","volume":"30","author":"Xu","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ynpai.2021.100067_b0385","doi-asserted-by":"crossref","unstructured":"Yin K, Deuis L JR, RJ V, I. Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target. Mol Pain. 2016;12(1744806916665366). doi:10.1177\/1744806916665366.","DOI":"10.1177\/1744806916665366"},{"issue":"1","key":"10.1016\/j.ynpai.2021.100067_b0390","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-019-0385-8","article-title":"Cholecystokinin type B receptor-mediated inhibition of A-type K+ channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway","volume":"17","author":"Yu","year":"2019","journal-title":"Cell Commun Signal."},{"key":"10.1016\/j.ynpai.2021.100067_b0395","doi-asserted-by":"crossref","unstructured":"Zhang W, Gardell S, Zhang D, et al. Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors. Brain J Neurol. 2009;132(Pt 3):778-787. doi:10.1093\/brain\/awn330.","DOI":"10.1093\/brain\/awn330"},{"issue":"3","key":"10.1016\/j.ynpai.2021.100067_b0400","first-page":"15944741","article-title":"Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder","volume":"30","author":"Zwanzger","year":"2005","journal-title":"J. Psychiatry Neurosci."}],"updated-by":[{"DOI":"10.1016\/j.ynpai.2023.100127","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["Neurobiology of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452073X21000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452073X21000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T16:54:03Z","timestamp":1694364843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452073X21000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":80,"alternative-id":["S2452073X21000088"],"URL":"https:\/\/doi.org\/10.1016\/j.ynpai.2021.100067","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ynpai.2023.100127","asserted-by":"object"}]},"ISSN":["2452-073X"],"issn-type":[{"value":"2452-073X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ynpai.2021.100067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100067"}}